
Study Period | 2019 - 2030 |
Base Year For Estimation | 2024 |
Forecast Data Period | 2025 - 2030 |
Market Size (2025) | USD 19.90 Million |
Market Size (2030) | USD 27.03 Million |
CAGR (2025 - 2030) | 6.31 % |
Market Concentration | Low |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Vietnam Electrocardiograph (ECG) Market Analysis
The Vietnam Electrocardiograph Market size is estimated at USD 19.90 million in 2025, and is expected to reach USD 27.03 million by 2030, at a CAGR of 6.31% during the forecast period (2025-2030).
The electrocardiograph (ECG or EKG) is a vital medical device that records the heart's electrical activity. By capturing and displaying these electrical impulses enables healthcare providers to evaluate heart rhythm and identify potential problems, such as cardiovascular diseases. Various factors influence the dynamics of the ECG market in Vietnam, including the increasing prevalence of cardiovascular diseases (CVDs), the growing geriatric population, and technological advancements in ECG devices.
The high prevalence of cardiovascular diseases (CVDs) in Vietnam, including ischemic heart disease and stroke, primarily driven by lifestyle changes and urbanization, highlights the urgent need for advanced diagnostic tools like ECG devices to improve early detection and management. For instance, an article published by the United States Embassy & Consulate in Vietnam in January 2024 highlighted that Vietnam faces a significant stroke burden, recording approximately 200,000 new stroke cases annually, placing it among the nations with the highest stroke incidence rates. This significant stroke burden is expected to drive the demand for advanced diagnostic tools, including electrocardiogram (ECG) devices, thereby contributing to the growth of the Vietnam ECG market in the coming years.
The increasing aging population in Vietnam is contributing to a rise in age-related cardiac problems, which in turn is driving increased demand for ECG monitoring. For instance, the data published by the Department of Population and Labour Statistics in 2024 highlighted that the elderly population (aged 60 and older) accounted for 14.2 million by 2024. This number is rapidly increasing, with projections estimating it will reach 18 million by 2030, highlighting the accelerating pace of aging in the country. This demographic shift is expected to drive significant growth in Vietnam's ECG market, as the aging population typically experiences a higher prevalence of cardiovascular conditions, increasing the demand for diagnostic and monitoring devices like ECG machines.
Thus, the Vietnam ECG market is expected to witness significant growth in the coming years, driven by the rising prevalence of cardiovascular diseases, the increasing aging population, and the growing need for advanced diagnostic tools. However, stringent regulations can impede product approval, leading to delays and increased costs for ECG technology companies, and ultimately, slow down the ECG market expansion in the country.
Vietnam Electrocardiograph (ECG) Market Trends
Resting 12-Lead ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
A resting 12-lead ECG system is a medical device that captures a comprehensive 12-view recording of the heart's electrical activity while the patient is at rest, aiding physicians in the diagnosis of diverse cardiac conditions. Technological advancements in ECG devices, government initiatives and healthcare investments majorly drive the studied segment growth.
The utilization of resting 12-lead systems by healthcare providers to diagnose cardiovascular conditions significantly contributes to the segment growth. For instance, in January 2024, the Journal of Cardiovascular Disease published a study highlighting that a trained healthcare professional at the Vietnam National Heart Institute recorded 12-lead ECGs from 28 probands with hypertrophic cardiomyopathy (HCM) and 56 of their relatives, all after a 10–15-minute rest. The findings suggested that families affected by HCM could benefit from an ECG-based model for detecting mutation carriers, especially when ECG results are combined with other relevant clinical information. The growing adoption of resting 12-lead ECG systems in Vietnam, driven by their utility in mutation detection and integration with clinical data, is expected to contribute significantly to the growth of this segment in the Vietnam ECG market.
The Vietnamese government is focusing on investments to improve healthcare infrastructure, prioritizing the safety and quality of medical equipment. For instance, in 2024, Vietnam secured USD 38 billion in foreign direct investment (FDI), underscoring its growing allure to investors and standing out amidst a regional trend in Southeast Asia. This investment will include private healthcare facilities to offer specialized departments with cutting-edge diagnostic technology, employ standardized treatment protocols that meet international benchmarks, and utilize integrated patient care systems linking primary and specialized services. As a result, Vietnam's ECG market is poised for a surge, particularly in the resting 12-lead ECG system segment, fueled by these advancements and investments in healthcare infrastructure.
Thus, the growth of the resting 12-lead ECG system segment in Vietnam's ECG market is being driven by advancements in diagnostic capabilities, government-backed investments in healthcare infrastructure, and the increasing adoption of innovative medical technologies. These factors collectively position the segment for robust expansion, addressing both clinical needs and the broader demand for high-quality healthcare solutions in the country.
Holter ECG Systems is Expected to Have the Fastest Growth in the Market Over the Forecast Period
A portable electrocardiogram (ECG) device known as a Holter ECG system records the heart's electrical activity continuously for 24 to 48 hours or even longer. This system is used while patients engage in their daily activities. Unlike a standard resting ECG, which only provides a brief view of heart activity, a Holter ECG system offers prolonged monitoring. This makes it beneficial in detecting heart rhythm abnormalities (arrhythmias) that might not be captured during a short ECG test. The Holter ECG system segment is expected to witness significant growth in the Vietnam ECG market, driven by its ability to offer continuous monitoring and its effectiveness in diagnosing arrhythmias that standard ECG tests may overlook.
The Holter ECG system segment growth is driven by factors such as rising health awareness and preventive care, government initiatives, and healthcare investments to address the growing burden of cardiovascular diseases.
The growing burden of obesity is expected to drive the higher demand for Holter ECG products. Obesity elevates the risk of atrial fibrillation (AFib), hypertension, and other cardiac disorders by causing electrical and structural changes in the heart. Holter ECGs are helpful in identifying intermittent arrhythmias missed by standard ECGs. Additionally, long-term Holter ECG monitoring is frequently needed for patients with hypertension or heart disease to monitor their heart function.
For instance, the report published by the World Obesity Federation in 2024, reported that around 36% of children aged 5-19 years will be affected with obesity in Vietnam by 2035. Thus, with the significant burdne of obesity-related cardiovascular risks, the adoption of Holter ECG systems is expected to surge, thereby contributing to segment growth.

Vietnam Electrocardiograph (ECG) Industry Overview
The electrocardiograph (ECG) market in Vietnam is fragmented, with a mix of international and domestic manufacturers competing for market share by supplying a variety of ECG devices. The increasing need for cardiac monitoring solutions throughout the country drives this competitive landscape. Some of the key market players include Nihon Kohden Corporation, Bionet, Koninklijke Philips N.V., SCHILLER AG, and GE Healthcare, among others.
Vietnam Electrocardiograph (ECG) Market Leaders
-
Nihon Kohden Corporation
-
Bionet
-
Koninklijke Philips N.V.
-
SCHILLER AG
-
GE Healthcare
- *Disclaimer: Major Players sorted in no particular order

Vietnam Electrocardiograph (ECG) Market News
- November 2024: Sun Group's Sun Serenia Hospital project is underway in An Thới Ward, Phú Quốc City, Kiên Giang Province, Vietnam. Upon its anticipated completion in December 2025, the hospital will provide a range of services, including cardiology, stroke prevention, emergency care, dentistry, and cosmetic surgery. Specialized healthcare departments catering to the elderly and patients with cardiovascular conditions, particularly a Cardiology and Stroke Prevention Department, are also planned. The development of specialized healthcare facilities, such as Sun Serenia Hospital, is expected to integrate ECG devices for cardiovascular health monitoring.
- September 2024: The Vietnam Medical Association and AstraZeneca, together with VNews television, launched the online seminar series “Giá Như 2024-2025” to promote health awareness and encourage healthy lifestyles on World Heart Day. The inaugural live stream, themed "Action from the Heart," focused on "Controlling blood lipids to prevent myocardial infarction and strokes," providing essential knowledge on managing and preventing cardiovascular diseases, a major health challenge. Thus, such increasing awareness initiatives to promote cardiovascular health are anticipated to fuel the adoption of ECG devices in the country.
Vietnam Electrocardiograph (ECG) Industry Segmentation
As per the scope of the report, an electrocardiogram (ECG) measures the heart's electrical activity, focusing on its rate and rhythm. The ECG device captures these electrical signals, producing a graphical representation of the heart's activity.
The Vietnam ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Vietnam electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
By Product Type | Resting ECG Systems |
Stress ECG Systems | |
Holter ECG Systems | |
ECG Management Software |
Vietnam Electrocardiograph (ECG) Market Research FAQs
How big is the Vietnam Electrocardiograph Market?
The Vietnam Electrocardiograph Market size is expected to reach USD 19.90 million in 2025 and grow at a CAGR of 6.31% to reach USD 27.03 million by 2030.
What is the current Vietnam Electrocardiograph Market size?
In 2025, the Vietnam Electrocardiograph Market size is expected to reach USD 19.90 million.
Who are the key players in Vietnam Electrocardiograph Market?
Nihon Kohden Corporation, Bionet, Koninklijke Philips N.V., SCHILLER AG and GE Healthcare are the major companies operating in the Vietnam Electrocardiograph Market.
What years does this Vietnam Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Vietnam Electrocardiograph Market size was estimated at USD 18.64 million. The report covers the Vietnam Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Vietnam Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Vietnam Electrocardiograph (ECG) Industry Report
Statistics for the 2025 Vietnam Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Vietnam Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.